David Sciberras was qualified in Human Biology at University of Surrey (BSc) and went on to complete Masters Degree in Biopharmacy at Chelsea College, and a PhD in Clinical Pharmacology at University of London, based at the Royal Free Hospital. He spent 25 years at Merck, GE Healthcare and Amgen managing early phase drug development in a wide variety of therapeutic areas. He is now at UCB with clinical pharmacology responsibility for early and some late phase drug development. Previous committee member of clinical section of British Pharmacological Society and Chair for Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI). Previous Chair of ABPI Experimental Medicines Group.
Click here to go back to webinar page.